Funded Tech Companies

Rampart Bioscience

Wondering who provided funding to Rampart Bioscience? OrbiMed, Forbion Capital Partners and RA Capital Management joined the equity holders in this biopharmaceutical company.

Company Overview

Company Name
Rampart Bioscience
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
300 West Clarendon Avenue 240
Phoenix, AZ 85013
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Rampart Bioscience is evolving a new class of medicines for patients with genetically driven diseases. We integrate capabilities from a variety of key scientific disciplines -- including gene delivery, protein sciences and clinical translation -- to leap beyond the limitations of current gene therapies. Powered by our novel non-viral DNA delivery system, we are on a path to achieve higher standards for potency, durability, redosability and safety. Together, we are working to reshape the treatment landscape for people in dire need of better options.
Profile
Rampart Bioscience LinkedIn Company Profile
Social Media
Rampart Bioscience Company Twitter Account
Company News
Rampart Bioscience News
Facebook
Rampart Bioscience on Facebook
YouTube
Rampart Bioscience on YouTube
Last Transaction
10/24/2023

Financing History

Date
Type
Amount
Venture Equity
$85,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Louis Breton
  Louis Breton LinkedIn Profile  Louis Breton Twitter Account  Louis Breton News  Louis Breton on Facebook
Chief Information Officer
Jeffrey Bartlett
  Jeffrey Bartlett LinkedIn Profile  Jeffrey Bartlett Twitter Account  Jeffrey Bartlett News  Jeffrey Bartlett on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Ramp Swaps | Ramped

 

Share this article

 


About Our VC Transaction Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary